Merck EBIT 2010-2024 | MKKGY
Merck annual and quarterly EBIT history from 2010 to 2024. EBIT can be defined as earnings before interest and taxes.
- Merck EBIT for the quarter ending June 30, 2024 was $0.854B, a 19.26% decline year-over-year.
- Merck EBIT for the twelve months ending June 30, 2024 was $3.603B, a 16.53% decline year-over-year.
- Merck 2023 annual EBIT was $3.907B, a 17.11% decline from 2022.
- Merck 2022 annual EBIT was $4.714B, a 4.64% decline from 2021.
- Merck 2021 annual EBIT was $4.943B, a 44.97% increase from 2020.
Merck Annual EBIT
(Millions of US $) |
| 2023 |
$3,907 |
| 2022 |
$4,714 |
| 2021 |
$4,943 |
| 2020 |
$3,410 |
| 2019 |
$2,374 |
| 2018 |
$2,038 |
| 2017 |
$2,854 |
| 2016 |
$2,747 |
| 2015 |
$2,045 |
| 2014 |
$2,342 |
| 2013 |
$2,893 |
| 2012 |
$1,984 |
| 2011 |
$1,555 |
| 2010 |
$12,338 |
| 2009 |
$10,807 |
Merck Quarterly EBIT
(Millions of US $) |
| 2024-06-30 |
$854 |
| 2024-03-31 |
$1,011 |
| 2023-12-31 |
$667 |
| 2023-09-30 |
$1,071 |
| 2023-06-30 |
$1,058 |
| 2023-03-31 |
$1,111 |
| 2022-12-31 |
$904 |
| 2022-09-30 |
$1,244 |
| 2022-06-30 |
$1,249 |
| 2022-03-31 |
$1,316 |
| 2021-12-31 |
$1,186 |
| 2021-09-30 |
$1,236 |
| 2021-06-30 |
$1,264 |
| 2021-03-31 |
$1,257 |
| 2020-12-31 |
$716 |
| 2020-09-30 |
$1,363 |
| 2020-06-30 |
$541 |
| 2020-03-31 |
$790 |
| 2019-12-31 |
$572 |
| 2019-09-30 |
$678 |
| 2019-06-30 |
$695 |
| 2019-03-31 |
$429 |
| 2018-12-31 |
$361 |
| 2018-09-30 |
$571 |
| 2018-06-30 |
$469 |
| 2018-03-31 |
$638 |
| 2017-12-31 |
$301 |
| 2017-09-30 |
$1,058 |
| 2017-06-30 |
$691 |
| 2017-03-31 |
$805 |
| 2016-12-31 |
$433 |
| 2016-09-30 |
$754 |
| 2016-06-30 |
$622 |
| 2016-03-31 |
$937 |
| 2015-12-31 |
$329 |
| 2015-09-30 |
$644 |
| 2015-06-30 |
$554 |
| 2015-03-31 |
$573 |
| 2014-12-31 |
$112 |
| 2014-09-30 |
$569 |
| 2014-06-30 |
$504 |
| 2014-03-31 |
$644 |
| 2013-12-31 |
$539 |
| 2013-09-30 |
$830 |
| 2013-06-30 |
$870 |
| 2013-03-31 |
$643 |
| 2012-12-31 |
$3,646 |
| 2012-09-30 |
$601 |
| 2012-06-30 |
$79 |
| 2012-03-31 |
$3,274 |
| 2011-12-31 |
$3,311 |
| 2011-09-30 |
$3,585 |
| 2011-06-30 |
$151 |
| 2011-03-31 |
$3,505 |
| 2010-12-31 |
$6,234 |
| 2010-09-30 |
$618 |
| 2010-06-30 |
$2,695 |
| 2010-03-31 |
$2,791 |
| 2009-12-31 |
$2,983 |
| 2009-09-30 |
$2,778 |
| 2009-06-30 |
$2,590 |
| 2009-03-31 |
$2,456 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
